\-\ Texto\\:\\ \ \(0\)\
\-\ general\\:\\ the\\ patient\\ is\\ a\\ white\\ male\\.\\ he\\ is\\ 170\\.2cm\\ tall\\ and\\ weighs\\ about\\ 98\\.7\\ kg\\ \\(bmi\\ 34\\.1\\)\\.\\ blood\\ pressure\\ on\\ the\\ left\\ arm\\ in\\ the\\ seated\\ position\\ is\\ 129\\/64\\.\\ appears\\ stated\\ age\\.\\ he\\ is\\ well\\ appearing\\ and\\ in\\ no\\ acute\\ distress\\.\ \(0\)\
\-\ heent\\ \\:\\ normocephalic\\,\\ non\\ traumatic\\.\\ pupils\\ were\\ equal\\ and\\ reactive\\ to\\ light\\.\\ \ \(0\)\
\-\ cardiac\\:\\ regular\\ rate\\ and\\ rhythm\\,\\ normal\\ s1\\ and\\ s2\\.\\ no\\ murmurs\\,\\ rubs\\,\\ or\\ gallops\\.\\ right\\ sided\\ scars\\ visible\\ from\\ healed\\ vats\\.\\ median\\ sternotomy\\ incision\\ is\\ well\\ healed\\.\\ \ \(0\)\
\-\ pulmonary\\ \\:\\ pattern\\ unlabored\\,\\ breath\\ sounds\\ are\\ clear\\ and\\ equal\\ bilaterally\\,\\ no\\ distress\\.\\ no\\ rales\\,\\ no\\ rhonchi\\,\\ no\\ wheezez\\.\ \(0\)\
\-\ abdomen\\:\\ non\\-distended\ \(0\)\
\-\ extremities\\:\\ no\\ cyanosis\\,\\ no\\ clubbing\\,\\ no\\ edema\\,\\ no\\ coolness\\ and\\ no\\ deformities\\.\\ \ \(0\)\
\-\ musculoskeletal\\:\\ 5\\+\\ muslce\\ strength\\ in\\ all\\ extremities\\,\\ gait\\ and\\ tone\\ are\\ normal\\.\ \(0\)\
\-\ this\\ patient\\ was\\ initially\\ treated\\ with\\ right\\ thoracotomy\\,\\ which\\ yielded\\ 2l\\ of\\ fluid\\.\\ this\\ procedure\\ significantly\\ improved\\ his\\ shortness\\ of\\ breath\\.\\ \ \(0\)\
\-\ he\\ then\\ underwent\\ a\\ right\\ vats\\ pleurectomy\\ and\\ was\\ then\\ referred\\ to\\ outpatient\\ an\\ outpatient\\ medical\\ oncologist\\ who\\ is\\ currently\\ managing\\ his\\ treatment\\.\ \(0\)\
\-\ he\\ currently\\ on\\ chemotherapy\\ under\\ supervision\\ of\\ a\\ medical\\ oncologist\\,\\ and\\ reports\\ that\\ he\\ is\\ doing\\ well\\.\ \(0\)\
\-\ images\\ 1\\ and\\ 2\\ represent\\ a\\ pre\\-operative\\ pet\\-ct\\.\\ the\\ patient\\ was\\ given\\ iv\\ 18f\\-fdg\\ followed\\ by\\ low\\-dose\\,\\ non\\ contrast\\ ct\\ from\\ the\\ skull\\ vertex\\ to\\ the\\ mid\\-thigh\\.\\ this\\ ct\\ was\\ obtained\\ for\\ attenuation\\ correction\\ and\\ anatomic\\ orientation\\ with\\ axial\\ reconstruction\\.\\ pet\\ followed\\,\\ encompassing\\ the\\ same\\ regions\\.\\ the\\ chest\\ was\\ found\\ to\\ show\\ mild\\ to\\ moderate\\ abnormal\\ fdg\\ uptake\\ within\\ the\\ right\\-sided\\ pleural\\ effusion\\/thickening\\.\\ \\ there\\ was\\ a\\ small\\ internal\\ decrease\\ in\\ size\\.\\ there\\ was\\ no\\ axillary\\,\\ mediastinal\\,\\ or\\ hilar\\ lymphadenopathy\\.\\ there\\ is\\ no\\ air\\-space\\ disease\\ or\\ suspicious\\ lung\\ nodule\\.\\ these\\ findings\\ are\\ consistent\\ with\\ low\\-grade\\ metabolically\\ active\\ malignant\\ epithelioid\\ neoplasm\\ consistent\\ with\\ mesothelioma\\ of\\ the\\ right\\-sided\\ pleura\\.\\ \ \(0\)\
\-\ image\\ 3\\ represents\\ erect\\ pa\\ and\\ lateral\\ chest\\ images\\ following\\ vats\\ pleurectomy\\.\\ these\\ films\\ demonstrate\\ post\\-sternotomy\\ midline\\ wires\\ and\\ clips\\.\\ of\\ note\\ there\\ is\\ mild\\ to\\ moderate\\ cardiomegaly\\ and\\ chronic\\ right\\ basolateral\\ pleural\\ thickening\\ of\\ the\\ inferior\\ right\\ minor\\ fissure\\.\\ a\\ mediport\\-type\\ catheter\\ is\\ visualized\\ overlying\\ the\\ superior\\ right\\ hemithorax\\ with\\ its\\ distal\\ extent\\ projecting\\ over\\ the\\ course\\ of\\ the\\ right\\ jugular\\ vein\\.\\ there\\ is\\ also\\ minor\\ bronchitis\\ interstitial\\ features\\ at\\ the\\ lung\\ bases\\.\\ there\\ is\\ no\\ acute\\ pathology\\ noted\\,\\ and\\ there\\ is\\ no\\ evidence\\ of\\ pneumothorax\\ or\\ definitive\\ infiltrates\\.\ \(0\)\
\-\ image\\ 4\\ represents\\ a\\ follow\\ up\\ study\\ approximately\\ 2\\ weeks\\ after\\ image\\ 3\\ was\\ obtained\\.\\ there\\ was\\ evidence\\ of\\ copd\\.\\ it\\ was\\ noted\\ that\\ there\\ was\\ pleural\\-parenchymal\\ scarring\\ of\\ the\\ right\\ lung\\ base\\.\\ the\\ same\\ medial\\ sternotomy\\ changes\\ were\\ noted\\,\\ as\\ was\\ the\\ mediport\\ placement\\ and\\ cardiomegaly\\.\\ at\\ this\\ point\\ there\\ was\\ no\\ active\\ pulmonary\\ disease\\ noted\\.\\ \ \(0\)\
\-\ images\\ 5\\,\\ 6\\,\\ and\\ 7\\ represent\\ post\\-operative\\ pet\\-ct\\ following\\ right\\-sided\\ vats\\ pleurectomy\\.\\ the\\ same\\ protocol\\ was\\ followed\\ as\\ for\\ the\\ pet\\-ct\\ shown\\ in\\ images\\ 1\\ and\\ 2\\.\\ there\\ was\\ found\\ to\\ be\\ minimal\\ abnormal\\ fdg\\ uptake\\ within\\ the\\ right\\-sided\\ pleura\\.\\ there\\ was\\ no\\ axillary\\,\\ supraclavicular\\,\\ mediastinal\\,\\ or\\ hilar\\ lymphadenopathy\\.\\ the\\ image\\ has\\ the\\ overall\\ appearance\\ of\\ postsurgical\\ inflammatory\\ changes\\,\\ although\\ residual\\ low\\-grade\\ metabolically\\ active\\ metastasis\\ cannot\\ be\\ excluded\\.\ \(0\)\
\-\ malignant\\ mesothelioma\\,\\ epithelioid\\ type\ \(0\)\
\-\ asbestosis\ \(10\)\
\-\ malignant\\ mesothelioma\ \(14\)\
\-\ this\\ patient\\ is\\ a\\ 77\\ year\\ old\\ male\\ who\\ presented\\ to\\ his\\ primary\\ care\\ physician\\ as\\ part\\ of\\ a\\ pre\\-operative\\ work\\-up\\ for\\ cataract\\ surgery\\.\\ on\\ cxr\\ it\\ was\\ noted\\ that\\ the\\ patient\\ has\\ a\\ pleural\\ effusion\\.\\ the\\ patient\\ did\\ note\\ that\\ he\\ had\\ increasing\\ shortness\\ of\\ breath\\,\\ but\\ did\\ not\\ think\\ to\\ address\\ this\\ issue\\ prior\\ to\\ his\\ pre\\-op\\ clearance\\.\\ \ \(0\)\
\-\ pmhx\\:\\ \ \(0\)\
\-\ gerd\\,\\ gout\\,\\ hyperlipidemia\\,\\ benign\\ tumor\\ of\\ colon\\,\\ osteoarthritis\\,\\ rheumatic\\ fever\\,\\ htn\\,\\ congestive\\ heart\\ failure\\,\\ cad\\,\\ myocardial\\ infarction\ \(0\)\
\-\ pshx\\:\\ \ \(0\)\
\-\ neck\\ surgery\\ in\\ childhood\\ \\(ages\\ 5\\ and\\ 10\\)\\,\\ cholecystecomy\\ s\\/p\\ gallbladder\\ rupture\\,\\ quadruple\\ bypass\\ surgery\\,\\ hemicolectomy\\,\\ avulsed\\ fingers\\,\\ vats\\,\\ right\\ pleurectomy\ \(0\)\
\-\ medications\\:\\ almethicone\\ 125mg\\,\\ albuterol\\-ipratropium\\,\\ oxycodone\\ 10mg\\,\\ senna\\ oral\\,\\ tamsulosin\\,\\ alprazolam\\,\\ isosorbide\\ mononitrate\\,\\ plavix\\,\\ aspirin\\,\\ lipitor\\,\\ allopurinol\\,\\ atenolol\\,\\ ranitidine\\,\\ fluoxetine\\,\\ nitroglycerin\\,\\ ferrous\\ sulfate\\.\\ \ \(0\)\
\-\ allergies\\:\\ adhesive\\ tape\\ \\(rash\\)\ \(0\)\
\-\ transfustions\\:\\ mr\\.\\ b\\ has\\ 2\\ blood\\ transfusions\\ as\\ a\\ result\\ of\\ rectal\\ bleeding\\ from\\ gi\\ tumors\\.\ \(0\)\
\-\ social\\:\\ 34\\ pack\\ year\\ smoking\\ histroy\\ \\(2\\ ppd\\ for\\ 17\\ years\\)\\,\\ quit\\ smoking\\ in\\ 1970\\.\\ history\\ of\\ alcohol\\ abuse\\,\\ sober\\ since\\ 2012\\ when\\ he\\ underwent\\ treatment\\ for\\ etoh\\ withdrawal\\.\\ he\\ denies\\ any\\ illicit\\ and\\/or\\ iv\\ drug\\ abuse\\.\\ mr\\.\\ b\\ has\\ 3\\ children\\.\\ he\\ lives\\ in\\ an\\ apartment\\ on\\ his\\ house\\,\\ which\\ his\\ daughter\\ occupies\\.\\ he\\ worked\\ as\\ at\\ chemical\\ plant\\ for\\ 40\\ years\\.\\ he\\ recalls\\ this\\ plant\\ is\\ adjacent\\ to\\ another\\ chemical\\ plant\\ which\\ used\\ asbestos\\ as\\ part\\ of\\ its\\ plastics\\ manufacturing\\ process\\.\ \(0\)\
\-\ this\\ patient\\ is\\ a\\ 77\\ year\\ old\\ white\\ male\\.\\ he\\ worked\\ in\\ a\\ factory\\ adject\\ to\\ a\\ chemical\\ plant\\,\\ which\\ used\\ asbestos\\ in\\ the\\ manufacturing\\ of\\ plastic\\ products\\.\\ he\\ states\\ that\\ he\\ remembers\\ hearing\\ that\\ during\\ the\\ day\\,\\ the\\ plant\\ would\\ vacuum\\ excess\\ asbestos\\ from\\ the\\ factory\\ floor\\ to\\ the\\ roof\\ of\\ the\\ building\\ and\\ then\\ vent\\ the\\ asbestos\\ out\\ the\\ stacks\\ of\\ the\\ factory\\ at\\ night\\.\\ in\\ fact\\,\\ the\\ patient\\'s\\ grown\\ son\\,\\ now\\ in\\ his\\ fifties\\,\\ recalls\\ there\\ often\\ being\\ a\\ thin\\ coating\\ of\\ \\?dust\\?\\ on\\ park\\ benches\\ in\\ the\\ morning\\ following\\ the\\ venting\\ from\\ the\\ plant\\.\\ \ \(0\)\
\-\ the\\ patient\\ states\\ that\\ he\\ worked\\ in\\ a\\ plant\\ approximately\\ 600\\ feet\\ from\\ the\\ asbestos\\-using\\ facility\\,\\ and\\ states\\ that\\ his\\ factory\\ was\\ under\\ negative\\ pressure\\,\\ resulting\\ in\\ outside\\ asbestos\\-containing\\ air\\ to\\ be\\ \\?sucked\\ into\\?\\ his\\ factory\\.\\ he\\ began\\ work\\ in\\ the\\ 1960s\\ and\\ worked\\ at\\ the\\ same\\ plant\\ for\\ 41\\ years\\ until\\ his\\ retirement\\ in\\ 2003\\.\\ he\\ also\\ lived\\ approximately\\ 1\\ mile\\ from\\ both\\ plants\\,\\ and\\ states\\ that\\ his\\ home\\ was\\ directly\\ downwind\\ from\\ the\\ factories\\.\\ unfortunately\\,\\ this\\ patient\\ reported\\ that\\ a\\ former\\ coworker\\ died\\ of\\ complications\\ from\\ mesothelioma\\.\\ \ \(0\)\
\-\ this\\ patient\\'s\\ mesothelioma\\ was\\ discovered\\ incidentally\\ as\\ part\\ of\\ pre\\-operative\\ clearance\\ for\\ a\\ propsed\\ opthalmologic\\ surgery\\.\\ as\\ part\\ of\\ his\\ pre\\-operative\\ work\\-up\\ a\\ chest\\ xray\\ was\\ ordered\\,\\ which\\ revealed\\ a\\ large\\ plueral\\ effusion\\.\\ he\\ recalls\\ that\\ at\\ the\\ time\\ of\\ discovery\\ he\\ did\\ have\\ shortness\\ of\\ breath\\ with\\ minimal\\ exersion\\,\\ stating\\ that\\ he\\ would\\ become\\ short\\ of\\ breath\\ \\?just\\ by\\ talking\\?\\.\\ \ \(0\)\
\-\ this\\ patient\\'s\\ case\\ is\\ typical\\ of\\ malignant\\ pleural\\ mesothelioma\\.\\ this\\ disease\\ typically\\ affects\\ patients\\ who\\ are\\ 60\\ years\\ and\\ older\\.\\ often\\,\\ these\\ patients\\ present\\ decades\\ after\\ an\\ exposure\\ to\\ asbestos\\ and\\ have\\ gradual\\,\\ worsening\\,\\ nonspecific\\ pulmonary\\ symptoms\\ including\\ but\\ not\\ limited\\ to\\:\\ chest\\ pain\\,\\ dyspnea\\,\\ cough\\,\\ hoarseness\\,\\ or\\ dysphagia\\.\ \(0\)\
\-\ physical\\ findings\\ at\\ the\\ time\\ of\\ diagnosis\\ generally\\ are\\ related\\ to\\ a\\ pleural\\ effusion\\,\\ which\\ is\\ often\\ present\\.\\ physical\\ exam\\ findings\\ may\\ include\\ unilateral\\ dullness\\ to\\ percussion\\ at\\ the\\ lung\\ base\\,\\ decreased\\ air\\ movement\\ on\\ side\\ of\\ involvement\\,\\ or\\ asymmetric\\ chest\\ wall\\ expansion\\ during\\ respiration\\ \\(2\\-6\\)\\.\ \(0\)\
\-\ the\\ primary\\ risk\\ factor\\ for\\ mesothelioma\\ is\\ asbestos\\ exposure\\.\\ the\\ fibers\\ of\\ asbestos\\,\\ a\\ naturally\\ occuring\\ mineral\\,\\ are\\ strong\\ and\\ resistant\\ to\\ heat\\,\\ and\\ have\\ been\\ used\\ in\\ the\\ production\\ of\\ insulation\\,\\ brakes\\,\\ shingles\\,\\ flooring\\ and\\ many\\ other\\ products\\.\\ if\\ asbestos\\ is\\ broken\\ up\\,\\ and\\ the\\ dust\\ is\\ inhaled\\ or\\ swallowed\\,\\ the\\ fibers\\ will\\ settle\\ in\\ the\\ lungs\\,\\ leading\\ to\\ irritation\\,\\ which\\ can\\ then\\ progress\\ to\\ mesothelioma\\.\\ the\\ exact\\ mechanism\\ of\\ this\\ malignant\\ transformation\\ is\\ poorly\\ understood\\.\\ the\\ development\\ of\\ mesothelioma\\ following\\ asbestos\\ exposure\\ may\\ be\\ a\\ \\ 20\\ \\-\\ 40\\ year\\ process\\.\\ of\\ note\\,\\ most\\ people\\ with\\ years\\ of\\ asbestos\\ exposure\\ never\\ develop\\ mesothelioma\\,\\ while\\ some\\ people\\,\\ with\\ only\\ minimal\\ exposure\\,\\ develop\\ the\\ disease\\.\\ given\\ this\\ variation\\,\\ a\\ predisposition\\ to\\ cancer\\ likely\\ plays\\ a\\ role\\ in\\ disease\\ progression\\.\\ additional\\ risk\\ factors\\ include\\,\\ living\\ with\\ someone\\ working\\ with\\ asbestos\\ \\(as\\ they\\ may\\ carry\\ the\\ fibers\\ home\\ on\\ their\\ clothing\\ and\\ skin\\)\\,\\ as\\ well\\ as\\ family\\ history\\ of\\ mesothelioma\\ \\(7\\-\\ 9\\)\\.\ \(0\)\
\-\ in\\ terms\\ of\\ imaging\\,\\ computed\\ tomography\\ \\(ct\\)\\ is\\ often\\ pursued\\ given\\ limited\\ sensitivity\\ and\\ specificity\\ with\\ cxr\\.\\ findings\\ include\\ unilateral\\ pleural\\ abnormalities\\ with\\ a\\ large\\ unilateral\\ pleural\\ effusion\\.\\ there\\ may\\ be\\ a\\ plural\\ mass\\ or\\ \\"rind\\"\\,\\ or\\ even\\ a\\ diffuse\\ pleural\\ thickening\\ in\\ the\\ absence\\ of\\ pleural\\ effusion\\.\\ there\\ can\\ be\\ ipsilateral\\ mediastinal\\ shift\\ due\\ to\\ encasement\\ of\\ the\\ lung\\ by\\ a\\ thick\\ \\"rind\\"of\\ tumor\\ and\\ relative\\ ipsilateral\\ lung\\ volume\\ loss\\.\\ when\\ positron\\ emission\\ tomography\\ \\(pet\\)\\ is\\ used\\ in\\ conjunction\\ with\\ ct\\,\\ \\ increased\\ uptake\\ of\\ fluorodeoxyglucose\\ \\(fdg\\)\\ is\\ observed\\.\ \(0\)\
\-\ for\\ the\\ diagnosis\\ of\\ malignant\\ mesothelioma\\,\\ clinical\\ suspicion\\ may\\ arise\\ with\\ respiratory\\ symptoms\\,\\ pleural\\ thickening\\ and\\/or\\ effusion\\ on\\ chest\\ imaging\\,\\ and\\ a\\ history\\ of\\ asbestos\\ exposure\\.\\ however\\,\\ ultimately\\,\\ a\\ biopsy\\ is\\ necessary\\ to\\ confirm\\ the\\ diagnosis\\.\ \(0\)\
\-\ once\\ diagnosed\\,\\ an\\ integrated\\ positron\\ emission\\ tomography\\ with\\ computed\\ tomography\\ \\(pet\\-ct\\)\\ is\\ the\\ initial\\ staging\\ assessment\\.\ \(0\)\
\-\ when\\ diagnosed\\ at\\ an\\ early\\ stage\\,\\ surgeons\\ may\\ remove\\ the\\ mesothelioma\\,\\ and\\ in\\ some\\ cases\\,\\ this\\ may\\ be\\ curative\\.\\ other\\ therapies\\ include\\ chemotherapy\\ and\\ radiation\\ therapy\\.\\ there\\ are\\ ongoing\\ clinical\\ trials\\ investigating\\ targeted\\ biological\\ and\\ gene\\ therapy\\.\ \(0\)\
\-\ overall\\,\\ however\\,\\ the\\ prognosis\\ is\\ poor\\.\\ the\\ survival\\ is\\ on\\ the\\ spectrum\\ of\\ 9\\ to\\ 17\\ months\\ after\\ diagnosis\\ and\\ few\\ patients\\ are\\ cured\\ \\(12\\)\\.\ \(0\)\
\-\ references\\ for\\ malignant\\ pleural\\ mesothelioma\ \(0\)\
\-\ 1\\.\\ husain\\ an\\,\\ colby\\ t\\,\\ ordonez\\ n\\,\\ et\\ al\\.\\ guidelines\\ for\\ pathologic\\ diagnosis\\ of\\ malignant\\ mesothelioma\\:\\ 2012\\ update\\ of\\ the\\ consensus\\ statement\\ from\\ the\\ international\\ mesothelioma\\ interest\\ group\\.\\ arch\\ pathol\\ lab\\ med\\ 2013\\;\\ 137\\:647\\.\ \(0\)\
\-\ 2\\.\\	socola\\ f\\,\\ loaiza\\-bonilla\\ a\\,\\ bustinza\\-linares\\ e\\,\\ et\\ al\\.\\ recurrent\\ thrombotic\\ thrombocytopenic\\ purpura\\-like\\ syndrome\\ as\\ a\\ paraneoplastic\\ phenomenon\\ \\ in\\ malignant\\ peritoneal\\ mesothelioma\\:\\ a\\ case\\ report\\ and\\ review\\ of\\ the\\ literature\\.\\ case\\ rep\\ oncol\\ med\\ 2012\\;\\ \\ 2012\\:619348\\.\ \(0\)\
\-\ 3\\.\\	wong\\ sf\\,\\ newland\\ l\\,\\ john\\ t\\,\\ white\\ sc\\.\\ paraneoplastic\\ leukocytoclastic\\ vasculitis\\ as\\ an\\ initial\\ presentation\\ \\ of\\ malignant\\ pleural\\ mesothelioma\\:\\ \\ a\\ case\\ report\\.\\ j\\ med\\ case\\ rep\\ 2012\\;\\ 6\\:261\\.\ \(0\)\
\-\ 4\\.\\	li\\ jy\\,\\ yong\\ ty\\,\\ kuss\\ bj\\,\\ et\\ al\\.\\ malignant\\ pleural\\ mesothelioma\\ with\\ associated\\ minimal\\ change\\ disease\\ and\\ acute\\ renal\\ \\ failure\\.\\ ren\\ \\ fail\\ 2010\\;\\ 32\\:1012\\.\ \(0\)\
\-\ 5\\.\\	bech\\ c\\,\\ s0rensen\\ jb\\.\\ polyneuropathy\\ \\ in\\ a\\ patient\\ with\\ malignant\\ pleural\\ mesothelioma\\:\\ \\ a\\ paraneoplastic\\ \\ syndrome\\.\\ j\\ thorac\\ oncol\\ \\ 2008\\;\\ \\ 3\\:1359\\.\ \(0\)\
\-\ 6\\.\\	tanriverdi\\ 0\\,\\ meydan\\ n\\,\\ barutca\\ s\\,\\ et\\ al\\.\\ anti\\-yo\\ antibody\\-mediated\\ paraneoplastic\\ cerebellar\\ degeneration\\ in\\ a\\ female\\ patient\\ with\\ pleural\\ malignant\\ mesothelioma\\.\\ jpn\\ j\\ clin\\ oncol\\ 2013\\;\\ 43\\:563\\.\ \(0\)\
\-\ 7\\.\\	malignant\\ pleural\\ mesothelioma\\.\\ fort\\ washington\\,\\ pa\\.\\:\\ national\\ comprehensive\\ cancer\\ network\\.\\ http\\:\\/\\/www\\.nccn\\.org\\/professionals\\/physician\\_gls\\/f\\_guidelines\\.asp\\.\\ \\ \\ accessed\\ sept\\ \\ 17\\,\\ 2015\\.\ \(0\)\
\-\ 8\\.\\	niederhuber\\ \\ je\\,\\ et\\ al\\.\\,\\ eds\\.\\ diseases\\ of\\ the\\ pleura\\ and\\ mediastinum\\.\\ in\\:\\ abeloff\\ s\\ clinical\\ oncology\\.\\ 5th\\ ed\\.\\ philadelphia\\,\\ pa\\.\\:\\ churchill\\ livingstone\\ elsevier\\;\\ 2014\\.\\ http\\:\\/\\/www\\.clinicalkey\\.com\\.\\ \\ \\ accessed\\ \\ \\ sept\\.\\ \\ 17\\,\\ 2015\\.\ \(0\)\
\-\ 9\\.\\	osha\\ fact\\ sheet\\:\\ asbestos\\.\\ occupational\\ safety\\ and\\ health\\ administration\\.\\ http\\:\\/\\/www\\.osha\\.gov\\/sl\\ tc\\/asbestos\\/hazards\\.html\\.\\ accessed\\ oct\\.\\ 7\\,\\ 2015\\.\ \(0\)\
\-\ 10\\.\\	presentation\\,\\ initial\\ evaluation\\,\\ and\\ prognosis\\ of\\ malignant\\ pleural\ \(0\)\
\-\ mesothelioma\\.\\ \\"malignant\\ mesothelioma\\ i\\ ct\\.\\ ed\\.\\ uptodate\\ \\.\\.\\ \\.\\ uptodate\\,\\ 5\\ oct\\ 2016\\.\\ web\\.\\ 05\\ june\\ 2017\\.\ \(0\)\
\-\ 11\\.\\	husain\\ an\\,\\ colby\\ t\\,\\ ordonez\\ n\\,\\ et\\ al\\.\\ guidelines\\ for\\ pathologic\\ diagnosis\\ of\\ malignant\\ mesothelioma\\:\\ 2012\\ update\\ of\\ the\\ consensus\\ statement\\ from\\ the\\ international\\ mesothelioma\\ interest\\ group\\.\\ arch\\ pathol\\ lab\\ med\\ 2013\\;\\ 137\\:647\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mesothelioma\\:\\ 0\\.41971847710040233\ \(0\)\
\-\ asbestos\\:\\ 0\\.2696361682945397\ \(0\)\
\-\ the\\:\\ 0\\.20644899823355692\ \(0\)\
\-\ pleural\\:\\ 0\\.19746076235706606\ \(0\)\
\-\ plant\\:\\ 0\\.17814973855839658\ \(0\)\
\-\ malignant\\:\\ 0\\.17659198286794367\ \(0\)\
\-\ he\\:\\ 0\\.1725854481096911\ \(0\)\
\-\ of\\:\\ 0\\.15114351955688438\ \(0\)\
\-\ and\\:\\ 0\\.13550485362271078\ \(0\)\
\-\ is\\:\\ 0\\.1157321912477763\ \(0\)\
\-\ factory\\:\\ 0\\.10766900206890147\ \(0\)\
\-\ was\\:\\ 0\\.10665152586077166\ \(0\)\
\-\ his\\:\\ 0\\.10605409626730095\ \(0\)\
\-\ in\\:\\ 0\\.10150429325146637\ \(0\)\
\-\ 2012\\:\\ 0\\.0955244267442818\ \(0\)\
\-\ vats\\:\\ 0\\.09474774830774403\ \(0\)\
\-\ there\\:\\ 0\\.09277334015444655\ \(0\)\
\-\ to\\:\\ 0\\.0910771146298186\ \(0\)\
\-\ pleurectomy\\:\\ 0\\.08385501829948327\ \(0\)\
\-\ exposure\\:\\ 0\\.08309474031119746\ \(0\)\
\-\ pet\\:\\ 0\\.0809772148403215\ \(0\)\
\-\ no\\:\\ 0\\.08055952940642674\ \(0\)\
\-\ as\\:\\ 0\\.07610552933750436\ \(0\)\
\-\ that\\:\\ 0\\.07588677651202246\ \(0\)\
\-\ effusion\\:\\ 0\\.07574831412975981\ \(0\)\
\-\ this\\:\\ 0\\.07511035836046094\ \(0\)\
\-\ paraneoplastic\\:\\ 0\\.07196940878491075\ \(0\)\
\-\ worked\\:\\ 0\\.06968922542927283\ \(0\)\
\-\ al\\:\\ 0\\.06947218629767522\ \(0\)\
\-\ et\\:\\ 0\\.06849268867309175\ \(0\)\
\-\ patient\\:\\ 0\\.06635562296997206\ \(0\)\
\-\ from\\:\\ 0\\.06366316506016673\ \(0\)\
\-\ fdg\\:\\ 0\\.06313046744867146\ \(0\)\
\-\ right\\:\\ 0\\.06280782382836188\ \(0\)\
\-\ or\\:\\ 0\\.06083396232251665\ \(0\)\
\-\ med\\:\\ 0\\.058634843042010144\ \(0\)\
\-\ recalls\\:\\ 0\\.05838655802479872\ \(0\)\
\-\ oncol\\:\\ 0\\.057579091398283544\ \(0\)\
\-\ for\\:\\ 0\\.05741838201758489\ \(0\)\
\-\ tomography\\:\\ 0\\.05645910822331361\ \(0\)\
\-\ breath\\:\\ 0\\.0534026560308134\ \(0\)\
\-\ lung\\:\\ 0\\.053187548965034664\ \(0\)\
\-\ sternotomy\\:\\ 0\\.052266919071954625\ \(0\)\
\-\ part\\:\\ 0\\.05208520461539385\ \(0\)\
\-\ with\\:\\ 0\\.05136243207412215\ \(0\)\
\-\ may\\:\\ 0\\.0513332243799065\ \(0\)\
\-\ states\\:\\ 0\\.051211299744456824\ \(0\)\
\-\ ct\\:\\ 0\\.04993082652499047\ \(0\)\
\-\ at\\:\\ 0\\.04953779927894936\ \(0\)\
\-\ accessed\\:\\ 0\\.04941931368985023\ \(0\)\
\-\ 2015\\:\\ 0\\.04915949746368354\ \(0\)\
\-\ 2013\\:\\ 0\\.0477622133721409\ \(0\)\
\-\ 17\\:\\ 0\\.04758339657189508\ \(0\)\
\-\ chemical\\:\\ 0\\.047552231889803585\ \(0\)\
\-\ sided\\:\\ 0\\.046868721938447204\ \(0\)\
\-\ pleura\\:\\ 0\\.04658082650593213\ \(0\)\
\-\ which\\:\\ 0\\.04638367506641972\ \(0\)\
\-\ chest\\:\\ 0\\.04615247432503465\ \(0\)\
\-\ same\\:\\ 0\\.04610938777707463\ \(0\)\
\-\ diagnosis\\:\\ 0\\.045325537595372986\ \(0\)\
\-\ years\\:\\ 0\\.04466359297636221\ \(0\)\
\-\ an\\:\\ 0\\.04457965639992413\ \(0\)\
\-\ manufacturing\\:\\ 0\\.044537434639599145\ \(0\)\
\-\ husain\\:\\ 0\\.044537434639599145\ \(0\)\
\-\ colby\\:\\ 0\\.044537434639599145\ \(0\)\
\-\ ordonez\\:\\ 0\\.044537434639599145\ \(0\)\
\-\ osha\\:\\ 0\\.044537434639599145\ \(0\)\
\-\ minimal\\:\\ 0\\.0444690501717997\ \(0\)\
\-\ fibers\\:\\ 0\\.04424042897823251\ \(0\)\
\-\ are\\:\\ 0\\.04423666481095919\ \(0\)\
\-\ used\\:\\ 0\\.043637823044489876\ \(0\)\
\-\ metabolically\\:\\ 0\\.04306760082756059\ \(0\)\
\-\ dust\\:\\ 0\\.04192750914974164\ \(0\)\
\-\ statement\\:\\ 0\\.04192750914974164\ \(0\)\
\-\ rep\\:\\ 0\\.04192750914974164\ \(0\)\
\-\ be\\:\\ 0\\.04138023079421166\ \(0\)\
\-\ then\\:\\ 0\\.0412622878968596\ \(0\)\
\-\ update\\:\\ 0\\.040995986422046535\ \(0\)\
\-\ unilateral\\:\\ 0\\.040009461115446426\ \(0\)\
\-\ thickening\\:\\ 0\\.03965551818230952\ \(0\)\
\-\ on\\:\\ 0\\.039610178007038824\ \(0\)\
\-\ rind\\:\\ 0\\.039526152610007984\ \(0\)\
\-\ positron\\:\\ 0\\.039526152610007984\ \(0\)\
\-\ sept\\:\\ 0\\.039526152610007984\ \(0\)\
\-\ epithelioid\\:\\ 0\\.03892437201653248\ \(0\)\
\-\ noted\\:\\ 0\\.03863146578936808\ \(0\)\
\-\ mediport\\:\\ 0\\.03838606093218903\ \(0\)\
\-\ often\\:\\ 0\\.038034098241555986\ \(0\)\
\-\ pathol\\:\\ 0\\.03789909932309762\ \(0\)\
\-\ image\\:\\ 0\\.037278476664873016\ \(0\)\
\-\ oncologist\\:\\ 0\\.03704558161869416\ \(0\)\
\-\ emission\\:\\ 0\\.03704558161869416\ \(0\)\
\-\ disease\\:\\ 0\\.036701988069806714\ \(0\)\
\-\ consensus\\:\\ 0\\.03666694696035475\ \(0\)\
\-\ case\\:\\ 0\\.036605209222261834\ \(0\)\
\-\ interest\\:\\ 0\\.03631444652667497\ \(0\)\
\-\ work\\:\\ 0\\.03564362842808852\ \(0\)\
\-\ clearance\\:\\ 0\\.03538292379897987\ \(0\)\
\-\ guidelines\\:\\ 0\\.03538292379897987\ \(0\)\
\-\ international\\:\\ 0\\.03538292379897987\ \(0\)\
\-\ mediastinal\\:\\ 0\\.035301053200071535\ \(0\)\
\-\ shortness\\:\\ 0\\.03505381096306105\ \(0\)\
\-\ following\\:\\ 0\\.0349683459497493\ \(0\)\
\-\ include\\:\\ 0\\.0346819070589497\ \(0\)\
\-\ people\\:\\ 0\\.033913089986941314\ \(0\)\
\-\ uptodate\\:\\ 0\\.033913089986941314\ \(0\)\
\-\ oct\\:\\ 0\\.03370452103681746\ \(0\)\
\-\ uptake\\:\\ 0\\.03361608432557468\ \(0\)\
\-\ pa\\:\\ 0\\.033549150758883185\ \(0\)\
\-\ note\\:\\ 0\\.03291012705951101\ \(0\)\
\-\ active\\:\\ 0\\.03246356319846849\ \(0\)\
\-\ http\\:\\ 0\\.032320309594483544\ \(0\)\
\-\ did\\:\\ 0\\.031361078708281996\ \(0\)\
\-\ surgery\\:\\ 0\\.03133906799524574\ \(0\)\
\-\ healed\\:\\ 0\\.030933661619157518\ \(0\)\
\-\ products\\:\\ 0\\.0308162028879924\ \(0\)\
\-\ cardiomegaly\\:\\ 0\\.030479208474654445\ \(0\)\
\-\ abuse\\:\\ 0\\.030371641769388707\ \(0\)\
\-\ ipsilateral\\:\\ 0\\.03016307281926485\ \(0\)\
\-\ given\\:\\ 0\\.030073099794574672\ \(0\)\
\-\ outpatient\\:\\ 0\\.029865363578569837\ \(0\)\
\-\ followed\\:\\ 0\\.029521800118088682\ \(0\)\
\-\ initial\\:\\ 0\\.029327275851094837\ \(0\)\
\-\ 77\\:\\ 0\\.02914709808978102\ \(0\)\
\-\ white\\:\\ 0\\.02884347456503838\ \(0\)\
\-\ up\\:\\ 0\\.028833773238280538\ \(0\)\
\-\ findings\\:\\ 0\\.02876835992213915\ \(0\)\
\-\ axillary\\:\\ 0\\.02866775651160398\ \(0\)\
\-\ air\\:\\ 0\\.02859508748810024\ \(0\)\
\-\ well\\:\\ 0\\.028224214004504734\ \(0\)\
\-\ computed\\:\\ 0\\.028091458413750794\ \(0\)\
\-\ fact\\:\\ 0\\.02795699723833917\ \(0\)\
\-\ approximately\\:\\ 0\\.02789485842384611\ \(0\)\
\-\ equal\\:\\ 0\\.027891070778074886\ \(0\)\
\-\ clinical\\:\\ 0\\.027706006699662424\ \(0\)\
\-\ group\\:\\ 0\\.02769824677039915\ \(0\)\
\-\ minor\\:\\ 0\\.027392213401604908\ \(0\)\
\-\ smoking\\:\\ 0\\.026992404946773834\ \(0\)\
\-\ images\\:\\ 0\\.026962918489761258\ \(0\)\
\-\ develop\\:\\ 0\\.026830193551836103\ \(0\)\
\-\ overall\\:\\ 0\\.026777247691699632\ \(0\)\
\-\ hilar\\:\\ 0\\.02672484487559631\ \(0\)\
\-\ pulmonary\\:\\ 0\\.026647745442691596\ \(0\)\
\-\ has\\:\\ 0\\.026625087405661656\ \(0\)\
\-\ when\\:\\ 0\\.026407814188498472\ \(0\)\
\-\ lab\\:\\ 0\\.026323915361017226\ \(0\)\
\-\ represents\\:\\ 0\\.026042602307696925\ \(0\)\
\-\ home\\:\\ 0\\.02577597330345246\ \(0\)\
\-\ prognosis\\:\\ 0\\.025647701383529422\ \(0\)\
\-\ 34\\:\\ 0\\.025400432335659306\ \(0\)\
\-\ who\\:\\ 0\\.024729236817969395\ \(0\)\
\-\ arch\\:\\ 0\\.024723221013642643\ \(0\)\
\-\ these\\:\\ 0\\.024687185438548465\ \(0\)\
\-\ patients\\:\\ 0\\.024593405067759495\ \(0\)\
\-\ report\\:\\ 0\\.024550010196198183\ \(0\)\
\-\ represent\\:\\ 0\\.02425230095550317\ \(0\)\
\-\ under\\:\\ 0\\.024125357039585484\ \(0\)\
\-\ pathologic\\:\\ 0\\.023880556695755006\ \(0\)\
\-\ acute\\:\\ 0\\.02364941955096075\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.0235620313163831\ \(0\)\
\-\ distress\\:\\ 0\\.02347849981361155\ \(0\)\
\-\ cxr\\:\\ 0\\.02331542544598685\ \(0\)\
\-\ ed\\:\\ 0\\.02331542544598685\ \(0\)\
\-\ transfustions\\:\\ 0\\.0233045245225566\ \(0\)\
\-\ limited\\:\\ 0\\.023262203821187998\ \(0\)\
\-\ currently\\:\\ 0\\.022388362980278225\ \(0\)\
\-\ wheezez\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ coolness\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ muslce\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ supervision\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ basolateral\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ quadruple\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ almethicone\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ senna\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ alprazolam\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ isosorbide\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ mononitrate\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ fluoxetine\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ ferrous\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ tape\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ histroy\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ adject\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ stacks\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ fifties\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ benches\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ venting\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ sucked\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ 1960s\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ plants\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ downwind\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ factories\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ coworker\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ propsed\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ plueral\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ exersion\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ insulation\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ flooring\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ investigating\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ socola\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ newland\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ leukocytoclastic\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ ty\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ kuss\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ ren\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ bech\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ s0rensen\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ tanriverdi\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ meydan\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ barutca\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ jpn\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ niederhuber\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ abeloff\\:\\ 0\\.022268717319799573\ \(0\)\
\-\ pressure\\:\\ 0\\.022191408966896215\ \(0\)\
\-\ base\\:\\ 0\\.022169986588421814\ \(0\)\
\-\ extremities\\:\\ 0\\.022148653656464536\ \(0\)\
\-\ failure\\:\\ 0\\.02212740942718316\ \(0\)\
\-\ moderate\\:\\ 0\\.021879138896830713\ \(0\)\
\-\ process\\:\\ 0\\.021858984118106696\ \(0\)\
\-\ have\\:\\ 0\\.021839218545810665\ \(0\)\
\-\ its\\:\\ 0\\.021565831265746682\ \(0\)\
\-\ unlabored\\:\\ 0\\.021533800413780294\ \(0\)\
\-\ 125mg\\:\\ 0\\.021533800413780294\ \(0\)\
\-\ tamsulosin\\:\\ 0\\.021533800413780294\ \(0\)\
\-\ sober\\:\\ 0\\.021533800413780294\ \(0\)\
\-\ opthalmologic\\:\\ 0\\.021533800413780294\ \(0\)\
\-\ settle\\:\\ 0\\.021533800413780294\ \(0\)\
\-\ sf\\:\\ 0\\.021533800413780294\ \(0\)\
\-\ jy\\:\\ 0\\.021533800413780294\ \(0\)\
\-\ yong\\:\\ 0\\.021533800413780294\ \(0\)\
\-\ fort\\:\\ 0\\.021533800413780294\ \(0\)\
\-\ washington\\:\\ 0\\.021533800413780294\ \(0\)\
\-\ sheet\\:\\ 0\\.021533800413780294\ \(0\)\
\-\ 40\\:\\ 0\\.021434577778227024\ \(0\)\
\-\ after\\:\\ 0\\.02120800727254426\ \(0\)\
\-\ diagnosed\\:\\ 0\\.021111782252529642\ \(0\)\
\-\ managing\\:\\ 0\\.02096375457487082\ \(0\)\
\-\ cholecystecomy\\:\\ 0\\.02096375457487082\ \(0\)\
\-\ ranitidine\\:\\ 0\\.02096375457487082\ \(0\)\
\-\ nitroglycerin\\:\\ 0\\.02096375457487082\ \(0\)\
\-\ apartment\\:\\ 0\\.02096375457487082\ \(0\)\
\-\ plastics\\:\\ 0\\.02096375457487082\ \(0\)\
\-\ building\\:\\ 0\\.02096375457487082\ \(0\)\
\-\ retirement\\:\\ 0\\.02096375457487082\ \(0\)\
\-\ iv\\:\\ 0\\.02082457637882504\ \(0\)\
\-\ risk\\:\\ 0\\.02082457637882504\ \(0\)\
\-\ non\\:\\ 0\\.020742997925749365\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.020694811186998625\ \(0\)\
\-\ would\\:\\ 0\\.0206311439484298\ \(0\)\
\-\ obtained\\:\\ 0\\.020615350335293933\ \(0\)\
\-\ lipitor\\:\\ 0\\.020497993211023267\ \(0\)\
\-\ mile\\:\\ 0\\.020497993211023267\ \(0\)\
\-\ brakes\\:\\ 0\\.020497993211023267\ \(0\)\
\-\ shingles\\:\\ 0\\.020497993211023267\ \(0\)\
\-\ clothing\\:\\ 0\\.020497993211023267\ \(0\)\
\-\ biological\\:\\ 0\\.020497993211023267\ \(0\)\
\-\ wong\\:\\ 0\\.020497993211023267\ \(0\)\
\-\ thorac\\:\\ 0\\.020497993211023267\ \(0\)\
\-\ network\\:\\ 0\\.020497993211023267\ \(0\)\
\-\ encompassing\\:\\ 0\\.02010419758895368\ \(0\)\
\-\ erect\\:\\ 0\\.02010419758895368\ \(0\)\
\-\ atenolol\\:\\ 0\\.02010419758895368\ \(0\)\
\-\ vent\\:\\ 0\\.02010419758895368\ \(0\)\
\-\ stating\\:\\ 0\\.02010419758895368\ \(0\)\
\-\ talking\\:\\ 0\\.02010419758895368\ \(0\)\
\-\ naturally\\:\\ 0\\.02010419758895368\ \(0\)\
\-\ mineral\\:\\ 0\\.02010419758895368\ \(0\)\
\-\ fluorodeoxyglucose\\:\\ 0\\.02010419758895368\ \(0\)\
\-\ targeted\\:\\ 0\\.02010419758895368\ \(0\)\
\-\ thrombocytopenic\\:\\ 0\\.02010419758895368\ \(0\)\
\-\ underwent\\:\\ 0\\.020077039250950477\ \(0\)\
\-\ presentation\\:\\ 0\\.020062866621110863\ \(0\)\
\-\ 2l\\:\\ 0\\.019763076305003992\ \(0\)\
\-\ oxycodone\\:\\ 0\\.019763076305003992\ \(0\)\
\-\ allopurinol\\:\\ 0\\.019763076305003992\ \(0\)\
\-\ sulfate\\:\\ 0\\.019763076305003992\ \(0\)\
\-\ remembers\\:\\ 0\\.019763076305003992\ \(0\)\
\-\ coating\\:\\ 0\\.019763076305003992\ \(0\)\
\-\ park\\:\\ 0\\.019763076305003992\ \(0\)\
\-\ inhaled\\:\\ 0\\.019763076305003992\ \(0\)\
\-\ plural\\:\\ 0\\.019763076305003992\ \(0\)\
\-\ integrated\\:\\ 0\\.019763076305003992\ \(0\)\
\-\ type\\:\\ 0\\.019551517234063225\ \(0\)\
\-\ male\\:\\ 0\\.019464649744236836\ \(0\)\
\-\ rheumatic\\:\\ 0\\.01946218600826624\ \(0\)\
\-\ occupies\\:\\ 0\\.01946218600826624\ \(0\)\
\-\ lived\\:\\ 0\\.01946218600826624\ \(0\)\
\-\ jb\\:\\ 0\\.01946218600826624\ \(0\)\
\-\ cancer\\:\\ 0\\.019412567934988904\ \(0\)\
\-\ cataract\\:\\ 0\\.019193030466094513\ \(0\)\
\-\ 10mg\\:\\ 0\\.019193030466094513\ \(0\)\
\-\ withdrawal\\:\\ 0\\.019193030466094513\ \(0\)\
\-\ house\\:\\ 0\\.019193030466094513\ \(0\)\
\-\ respiration\\:\\ 0\\.019193030466094513\ \(0\)\
\-\ plays\\:\\ 0\\.019193030466094513\ \(0\)\
\-\ pursued\\:\\ 0\\.019193030466094513\ \(0\)\
\-\ cured\\:\\ 0\\.019193030466094513\ \(0\)\
\-\ je\\:\\ 0\\.019193030466094513\ \(0\)\
\-\ livingstone\\:\\ 0\\.019193030466094513\ \(0\)\
\-\ dullness\\:\\ 0\\.01894954966154881\ \(0\)\
\-\ predisposition\\:\\ 0\\.01894954966154881\ \(0\)\
\-\ sc\\:\\ 0\\.01894954966154881\ \(0\)\
\-\ churchill\\:\\ 0\\.01894954966154881\ \(0\)\
\-\ found\\:\\ 0\\.018858082482540308\ \(0\)\
\-\ mr\\:\\ 0\\.018858082482540308\ \(0\)\
\-\ postsurgical\\:\\ 0\\.018727269102246962\ \(0\)\
\-\ address\\:\\ 0\\.018727269102246962\ \(0\)\
\-\ avulsed\\:\\ 0\\.018727269102246962\ \(0\)\
\-\ plavix\\:\\ 0\\.018727269102246962\ \(0\)\
\-\ adhesive\\:\\ 0\\.018727269102246962\ \(0\)\
\-\ daughter\\:\\ 0\\.018727269102246962\ \(0\)\
\-\ vacuum\\:\\ 0\\.018727269102246962\ \(0\)\
\-\ swallowed\\:\\ 0\\.018727269102246962\ \(0\)\
\-\ someone\\:\\ 0\\.018727269102246962\ \(0\)\
\-\ safety\\:\\ 0\\.018727269102246962\ \(0\)\
\-\ by\\:\\ 0\\.018564925919882447\ \(0\)\
\-\ think\\:\\ 0\\.01852279080934708\ \(0\)\
\-\ pshx\\:\\ 0\\.01852279080934708\ \(0\)\
\-\ hemicolectomy\\:\\ 0\\.01852279080934708\ \(0\)\
\-\ quit\\:\\ 0\\.01852279080934708\ \(0\)\
\-\ son\\:\\ 0\\.01852279080934708\ \(0\)\
\-\ carry\\:\\ 0\\.01852279080934708\ \(0\)\
\-\ john\\:\\ 0\\.01852279080934708\ \(0\)\
\-\ medical\\:\\ 0\\.01852275343712319\ \(0\)\
\-\ during\\:\\ 0\\.018460318080364076\ \(0\)\
\-\ some\\:\\ 0\\.018337690679278103\ \(0\)\
\-\ thoracotomy\\:\\ 0\\.018333473480177376\ \(0\)\
\-\ cad\\:\\ 0\\.018333473480177376\ \(0\)\
\-\ grown\\:\\ 0\\.018333473480177376\ \(0\)\
\-\ occuring\\:\\ 0\\.018333473480177376\ \(0\)\
\-\ bj\\:\\ 0\\.018333473480177376\ \(0\)\
\-\ bronchitis\\:\\ 0\\.018157223263337484\ \(0\)\
\-\ understood\\:\\ 0\\.018157223263337484\ \(0\)\
\-\ encasement\\:\\ 0\\.018157223263337484\ \(0\)\
\-\ trials\\:\\ 0\\.018157223263337484\ \(0\)\
\-\ eds\\:\\ 0\\.018157223263337484\ \(0\)\
\-\ broken\\:\\ 0\\.017992352196227687\ \(0\)\
\-\ fail\\:\\ 0\\.017992352196227687\ \(0\)\
\-\ year\\:\\ 0\\.0179637722321918\ \(0\)\
\-\ primary\\:\\ 0\\.01792097284364769\ \(0\)\
\-\ weighs\\:\\ 0\\.017837479634603637\ \(0\)\
\-\ asbestosis\\:\\ 0\\.017837479634603637\ \(0\)\
\-\ former\\:\\ 0\\.017837479634603637\ \(0\)\
\-\ discovery\\:\\ 0\\.017837479634603637\ \(0\)\
\-\ variation\\:\\ 0\\.017837479634603637\ \(0\)\
\-\ national\\:\\ 0\\.017837479634603637\ \(0\)\
\-\ elsevier\\:\\ 0\\.017837479634603637\ \(0\)\
\-\ yielded\\:\\ 0\\.017691461899489936\ \(0\)\
\-\ wires\\:\\ 0\\.017691461899489936\ \(0\)\
\-\ thrombotic\\:\\ 0\\.017691461899489936\ \(0\)\
\-\ comprehensive\\:\\ 0\\.017691461899489936\ \(0\)\
\-\ 05\\:\\ 0\\.017691461899489936\ \(0\)\
\-\ 2017\\:\\ 0\\.017691461899489936\ \(0\)\
\-\ changes\\:\\ 0\\.017613965639001642\ \(0\)\
\-\ syndrome\\:\\ 0\\.017570334034977035\ \(0\)\
\-\ transfusions\\:\\ 0\\.01755334097094417\ \(0\)\
\-\ 600\\:\\ 0\\.01755334097094417\ \(0\)\
\-\ polyneuropathy\\:\\ 0\\.01755334097094417\ \(0\)\
\-\ abnormal\\:\\ 0\\.017509869071524648\ \(0\)\
\-\ tall\\:\\ 0\\.017422306357318208\ \(0\)\
\-\ vertex\\:\\ 0\\.017422306357318208\ \(0\)\
\-\ issue\\:\\ 0\\.017422306357318208\ \(0\)\
\-\ plastic\\:\\ 0\\.01729766627742035\ \(0\)\
\-\ conjunction\\:\\ 0\\.01729766627742035\ \(0\)\
\-\ time\\:\\ 0\\.01727492056146557\ \(0\)\
\-\ however\\:\\ 0\\.017250376576166144\ \(0\)\
\-\ lives\\:\\ 0\\.017178825552772503\ \(0\)\
\-\ irritation\\:\\ 0\\.017178825552772503\ \(0\)\
\-\ scars\\:\\ 0\\.017065268418199456\ \(0\)\
\-\ excess\\:\\ 0\\.017065268418199456\ \(0\)\
\-\ hoarseness\\:\\ 0\\.017065268418199456\ \(0\)\
\-\ curative\\:\\ 0\\.017065268418199456\ \(0\)\
\-\ therapies\\:\\ 0\\.017065268418199456\ \(0\)\
\-\ gene\\:\\ 0\\.017065268418199456\ \(0\)\
\-\ occupational\\:\\ 0\\.017065268418199456\ \(0\)\
\-\ 10\\:\\ 0\\.017042460604480267\ \(0\)\
\-\ bmi\\:\\ 0\\.016956544993470657\ \(0\)\
\-\ living\\:\\ 0\\.016956544993470657\ \(0\)\
\-\ blood\\:\\ 0\\.016926248700299917\ \(0\)\
\-\ resistant\\:\\ 0\\.01685226051840873\ \(0\)\
\-\ aspirin\\:\\ 0\\.016752066700570774\ \(0\)\
\-\ etoh\\:\\ 0\\.016752066700570774\ \(0\)\
\-\ illicit\\:\\ 0\\.016752066700570774\ \(0\)\
\-\ phenomenon\\:\\ 0\\.016752066700570774\ \(0\)\
\-\ june\\:\\ 0\\.016752066700570774\ \(0\)\
\-\ therapy\\:\\ 0\\.01674563856254551\ \(0\)\
\-\ history\\:\\ 0\\.016702561783679175\ \(0\)\
\-\ seated\\:\\ 0\\.01665565469673291\ \(0\)\
\-\ specificity\\:\\ 0\\.01665565469673291\ \(0\)\
\-\ ppd\\:\\ 0\\.016562749371401075\ \(0\)\
\-\ terms\\:\\ 0\\.016562749371401075\ \(0\)\
\-\ evidence\\:\\ 0\\.016542692118322794\ \(0\)\
\-\ mild\\:\\ 0\\.016521418403558256\ \(0\)\
\-\ decades\\:\\ 0\\.01647310456328341\ \(0\)\
\-\ gradual\\:\\ 0\\.01647310456328341\ \(0\)\
\-\ clips\\:\\ 0\\.01638649915456118\ \(0\)\
\-\ working\\:\\ 0\\.01638649915456118\ \(0\)\
\-\ incision\\:\\ 0\\.01630273378492025\ \(0\)\
\-\ orientation\\:\\ 0\\.01630273378492025\ \(0\)\
\-\ ongoing\\:\\ 0\\.01622162808745138\ \(0\)\
\-\ xray\\:\\ 0\\.016143018350015477\ \(0\)\
\-\ heat\\:\\ 0\\.016143018350015477\ \(0\)\
\-\ infiltrates\\:\\ 0\\.01606675552582733\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.015992703532491596\ \(0\)\
\-\ bypass\\:\\ 0\\.015992703532491596\ \(0\)\
\-\ exact\\:\\ 0\\.015992703532491596\ \(0\)\
\-\ surgeons\\:\\ 0\\.015992703532491596\ \(0\)\
\-\ symptoms\\:\\ 0\\.01594644142232832\ \(0\)\
\-\ clubbing\\:\\ 0\\.01592073779071363\ \(0\)\
\-\ supraclavicular\\:\\ 0\\.01592073779071363\ \(0\)\
\-\ congestive\\:\\ 0\\.01592073779071363\ \(0\)\
\-\ normocephalic\\:\\ 0\\.015850743963267862\ \(0\)\
\-\ consistent\\:\\ 0\\.015803036907962798\ \(0\)\
\-\ physical\\:\\ 0\\.015803036907962798\ \(0\)\
\-\ myocardial\\:\\ 0\\.015716259497813745\ \(0\)\
\-\ rash\\:\\ 0\\.015716259497813745\ \(0\)\
\-\ roof\\:\\ 0\\.015716259497813745\ \(0\)\
\-\ remove\\:\\ 0\\.015716259497813745\ \(0\)\
\-\ web\\:\\ 0\\.015716259497813745\ \(0\)\
\-\ gerd\\:\\ 0\\.015651582248541903\ \(0\)\
\-\ production\\:\\ 0\\.015651582248541903\ \(0\)\
\-\ projecting\\:\\ 0\\.015588502132732844\ \(0\)\
\-\ fingers\\:\\ 0\\.015588502132732844\ \(0\)\
\-\ percussion\\:\\ 0\\.015588502132732844\ \(0\)\
\-\ oncology\\:\\ 0\\.015588502132732844\ \(0\)\
\-\ copd\\:\\ 0\\.015526942168644045\ \(0\)\
\-\ 2010\\:\\ 0\\.015526942168644045\ \(0\)\
\-\ rhonchi\\:\\ 0\\.015466830809578759\ \(0\)\
\-\ doing\\:\\ 0\\.015466830809578759\ \(0\)\
\-\ pmhx\\:\\ 0\\.0154081014439962\ \(0\)\
\-\ kg\\:\\ 0\\.015350691951804152\ \(0\)\
\-\ never\\:\\ 0\\.015350691951804152\ \(0\)\
\-\ imaging\\:\\ 0\\.015316634264987698\ \(0\)\
\-\ died\\:\\ 0\\.01529454430942315\ \(0\)\
\-\ role\\:\\ 0\\.01529454430942315\ \(0\)\
\-\ clin\\:\\ 0\\.01529454430942315\ \(0\)\
\-\ can\\:\\ 0\\.015294323182454668\ \(0\)\
\-\ tumor\\:\\ 0\\.015244476642874889\ \(0\)\
\-\ allergies\\:\\ 0\\.015239604237327222\ \(0\)\
\-\ ultimately\\:\\ 0\\.015239604237327222\ \(0\)\
\-\ strong\\:\\ 0\\.015185820884694353\ \(0\)\
\-\ other\\:\\ 0\\.015135417437465886\ \(0\)\
\-\ gallops\\:\\ 0\\.01513314654657446\ \(0\)\
\-\ cyanosis\\:\\ 0\\.01513314654657446\ \(0\)\
\-\ reconstruction\\:\\ 0\\.01513314654657446\ \(0\)\
\-\ social\\:\\ 0\\.01513314654657446\ \(0\)\
\-\ pack\\:\\ 0\\.01513314654657446\ \(0\)\
\-\ median\\:\\ 0\\.015081536409632425\ \(0\)\
\-\ jugular\\:\\ 0\\.015030948323070304\ \(0\)\
\-\ scarring\\:\\ 0\\.015030948323070304\ \(0\)\
\-\ unfortunately\\:\\ 0\\.015030948323070304\ \(0\)\
\-\ were\\:\\ 0\\.015023356730871592\ \(0\)\
\-\ correction\\:\\ 0\\.01498134259179447\ \(0\)\
\-\ bases\\:\\ 0\\.01498134259179447\ \(0\)\
\-\ present\\:\\ 0\\.014955197703483723\ \(0\)\
\-\ affects\\:\\ 0\\.014932681789284918\ \(0\)\
\-\ it\\:\\ 0\\.014918869862811466\ \(0\)\
\-\ ages\\:\\ 0\\.014884930587956605\ \(0\)\
\-\ transformation\\:\\ 0\\.014884930587956605\ \(0\)\
\-\ staging\\:\\ 0\\.014884930587956605\ \(0\)\
\-\ 2008\\:\\ 0\\.014884930587956605\ \(0\)\
\-\ hemithorax\\:\\ 0\\.014838055605086721\ \(0\)\
\-\ progress\\:\\ 0\\.014838055605086721\ \(0\)\
\-\ deformities\\:\\ 0\\.014792025262624768\ \(0\)\
\-\ sensitivity\\:\\ 0\\.014792025262624768\ \(0\)\
\-\ spectrum\\:\\ 0\\.014792025262624768\ \(0\)\
\-\ childhood\\:\\ 0\\.014746809659410836\ \(0\)\
\-\ rectal\\:\\ 0\\.014746809659410836\ \(0\)\
\-\ floor\\:\\ 0\\.014746809659410836\ \(0\)\
\-\ philadelphia\\:\\ 0\\.014746809659410836\ \(0\)\
\-\ gout\\:\\ 0\\.014702380454507105\ \(0\)\
\-\ rubs\\:\\ 0\\.014658710760502536\ \(0\)\
\-\ large\\:\\ 0\\.01460304449395583\ \(0\)\
\-\ htn\\:\\ 0\\.014532009676143945\ \(0\)\
\-\ directly\\:\\ 0\\.014491134965887015\ \(0\)\
\-\ pupils\\:\\ 0\\.014450903978675078\ \(0\)\
\-\ tone\\:\\ 0\\.014450903978675078\ \(0\)\
\-\ morning\\:\\ 0\\.014450903978675078\ \(0\)\
\-\ facility\\:\\ 0\\.014450903978675078\ \(0\)\
\-\ but\\:\\ 0\\.014412201401222744\ \(0\)\
\-\ stated\\:\\ 0\\.014411296752884991\ \(0\)\
\-\ health\\:\\ 0\\.014411296752884991\ \(0\)\
\-\ rales\\:\\ 0\\.01433387825580199\ \(0\)\
\-\ excluded\\:\\ 0\\.01433387825580199\ \(0\)\
\-\ assessment\\:\\ 0\\.014258737106666121\ \(0\)\
\-\ fissure\\:\\ 0\\.01422197942371529\ \(0\)\
\-\ protocol\\:\\ 0\\.01422197942371529\ \(0\)\
\-\ survival\\:\\ 0\\.01422197942371529\ \(0\)\
\-\ literature\\:\\ 0\\.01422197942371529\ \(0\)\
\-\ s2\\:\\ 0\\.01401189275339156\ \(0\)\
\-\ murmurs\\:\\ 0\\.013978498619169584\ \(0\)\
\-\ treatment\\:\\ 0\\.013883265053052636\ \(0\)\
\-\ thick\\:\\ 0\\.013849123385199575\ \(0\)\
\-\ suspicion\\:\\ 0\\.013849123385199575\ \(0\)\
\-\ rhythm\\:\\ 0\\.013817778023956541\ \(0\)\
\-\ musculoskeletal\\:\\ 0\\.013817778023956541\ \(0\)\
\-\ li\\:\\ 0\\.013817778023956541\ \(0\)\
\-\ mechanism\\:\\ 0\\.013725985578141548\ \(0\)\
\-\ also\\:\\ 0\\.013708928358613532\ \(0\)\
\-\ significantly\\:\\ 0\\.013696106700802454\ \(0\)\
\-\ feet\\:\\ 0\\.013696106700802454\ \(0\)\
\-\ nonspecific\\:\\ 0\\.013696106700802454\ \(0\)\
\-\ once\\:\\ 0\\.013696106700802454\ \(0\)\
\-\ peritoneal\\:\\ 0\\.013696106700802454\ \(0\)\
\-\ factor\\:\\ 0\\.013666573251750079\ \(0\)\
\-\ confirm\\:\\ 0\\.013637377335219894\ \(0\)\
\-\ began\\:\\ 0\\.013551739766967856\ \(0\)\
\-\ degeneration\\:\\ 0\\.013551739766967856\ \(0\)\
\-\ 5th\\:\\ 0\\.013551739766967856\ \(0\)\
\-\ anatomic\\:\\ 0\\.013523820200646845\ \(0\)\
\-\ older\\:\\ 0\\.013523820200646845\ \(0\)\
\-\ vasculitis\\:\\ 0\\.013523820200646845\ \(0\)\
\-\ alcohol\\:\\ 0\\.013468880128550917\ \(0\)\
\-\ within\\:\\ 0\\.013423244831033097\ \(0\)\
\-\ movement\\:\\ 0\\.013415096775918052\ \(0\)\
\-\ diseases\\:\\ 0\\.013388623845849816\ \(0\)\
\-\ 41\\:\\ 0\\.013362422437798154\ \(0\)\
\-\ progression\\:\\ 0\\.013362422437798154\ \(0\)\
\-\ extent\\:\\ 0\\.013336487038482142\ \(0\)\
\-\ arise\\:\\ 0\\.013336487038482142\ \(0\)\
\-\ definitive\\:\\ 0\\.013310812300856121\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.013310812300856121\ \(0\)\
\-\ discovered\\:\\ 0\\.013285393037493076\ \(0\)\
\-\ expansion\\:\\ 0\\.013285393037493076\ \(0\)\
\-\ residual\\:\\ 0\\.013260224214293998\ \(0\)\
\-\ drug\\:\\ 0\\.013260224214293998\ \(0\)\
\-\ hearing\\:\\ 0\\.01323530094450411\ \(0\)\
\-\ interstitial\\:\\ 0\\.013210618483018166\ \(0\)\
\-\ dysphagia\\:\\ 0\\.013161957680508613\ \(0\)\
\-\ poorly\\:\\ 0\\.013161957680508613\ \(0\)\
\-\ asymmetric\\:\\ 0\\.0131142064791803\ \(0\)\
\-\ night\\:\\ 0\\.013090661474808526\ \(0\)\
\-\ mediastinum\\:\\ 0\\.013044212651734529\ \(0\)\
\-\ heent\\:\\ 0\\.013021301153848462\ \(0\)\
\-\ suspicious\\:\\ 0\\.013021301153848462\ \(0\)\
\-\ gallbladder\\:\\ 0\\.013021301153848462\ \(0\)\
\-\ observed\\:\\ 0\\.012976085550634531\ \(0\)\
\-\ catheter\\:\\ 0\\.012953774361737367\ \(0\)\
\-\ leading\\:\\ 0\\.012953774361737367\ \(0\)\
\-\ improved\\:\\ 0\\.0129316563457308\ \(0\)\
\-\ become\\:\\ 0\\.0129316563457308\ \(0\)\
\-\ relative\\:\\ 0\\.012909728186280415\ \(0\)\
\-\ visible\\:\\ 0\\.01284505093700857\ \(0\)\
\-\ dyspnea\\:\\ 0\\.012823850691764711\ \(0\)\
\-\ ordered\\:\\ 0\\.012802824936114206\ \(0\)\
\-\ shift\\:\\ 0\\.012802824936114206\ \(0\)\
\-\ volume\\:\\ 0\\.012802824936114206\ \(0\)\
\-\ physician\\:\\ 0\\.012781970821199511\ \(0\)\
\-\ s1\\:\\ 0\\.012720410857110714\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.012700216167829653\ \(0\)\
\-\ light\\:\\ 0\\.012620996955288741\ \(0\)\
\-\ gait\\:\\ 0\\.012620996955288741\ \(0\)\
\-\ regular\\:\\ 0\\.012582289928564944\ \(0\)\
\-\ decrease\\:\\ 0\\.012525307308274721\ \(0\)\
\-\ short\\:\\ 0\\.012525307308274721\ \(0\)\
\-\ reactive\\:\\ 0\\.01250659209716701\ \(0\)\
\-\ regions\\:\\ 0\\.01250659209716701\ \(0\)\
\-\ overlying\\:\\ 0\\.012415019035172026\ \(0\)\
\-\ incidentally\\:\\ 0\\.012415019035172026\ \(0\)\
\-\ few\\:\\ 0\\.012361610506821321\ \(0\)\
\-\ generally\\:\\ 0\\.012344052947052098\ \(0\)\
\-\ factors\\:\\ 0\\.012326615235041126\ \(0\)\
\-\ poor\\:\\ 0\\.012292092886831592\ \(0\)\
\-\ even\\:\\ 0\\.012258030850329326\ \(0\)\
\-\ gi\\:\\ 0\\.012241168644615252\ \(0\)\
\-\ medications\\:\\ 0\\.01222441701153697\ \(0\)\
\-\ strength\\:\\ 0\\.01220777451039328\ \(0\)\
\-\ necessary\\:\\ 0\\.012191239728458161\ \(0\)\
\-\ resulting\\:\\ 0\\.012126150477751585\ \(0\)\
\-\ until\\:\\ 0\\.012126150477751585\ \(0\)\
\-\ their\\:\\ 0\\.012094217375820228\ \(0\)\
\-\ point\\:\\ 0\\.012047053915180236\ \(0\)\
\-\ development\\:\\ 0\\.012047053915180236\ \(0\)\
\-\ review\\:\\ 0\\.012000745428574013\ \(0\)\
\-\ children\\:\\ 0\\.011940278347877503\ \(0\)\
\-\ another\\:\\ 0\\.01192538259202615\ \(0\)\
\-\ cerebellar\\:\\ 0\\.01192538259202615\ \(0\)\
\-\ bleeding\\:\\ 0\\.011910573188867709\ \(0\)\
\-\ normal\\:\\ 0\\.01189966956412889\ \(0\)\
\-\ skull\\:\\ 0\\.011823475608890606\ \(0\)\
\-\ rupture\\:\\ 0\\.01178101565819155\ \(0\)\
\-\ denies\\:\\ 0\\.01175309609187054\ \(0\)\
\-\ features\\:\\ 0\\.011725478364610612\ \(0\)\
\-\ general\\:\\ 0\\.011698156019774615\ \(0\)\
\-\ outside\\:\\ 0\\.011698156019774615\ \(0\)\
\-\ recurrent\\:\\ 0\\.011684603654353686\ \(0\)\
\-\ oral\\:\\ 0\\.011671122805705777\ \(0\)\
\-\ just\\:\\ 0\\.011657712722993424\ \(0\)\
\-\ appearing\\:\\ 0\\.011644372667141743\ \(0\)\
\-\ arm\\:\\ 0\\.011631101910593999\ \(0\)\
\-\ position\\:\\ 0\\.01161789973707351\ \(0\)\
\-\ procedure\\:\\ 0\\.01161789973707351\ \(0\)\
\-\ absence\\:\\ 0\\.01161789973707351\ \(0\)\
\-\ references\\:\\ 0\\.01161789973707351\ \(0\)\
\-\ stage\\:\\ 0\\.011604765441351658\ \(0\)\
\-\ administration\\:\\ 0\\.011604765441351658\ \(0\)\
\-\ respiratory\\:\\ 0\\.011591698329021849\ \(0\)\
\-\ films\\:\\ 0\\.011540088192079816\ \(0\)\
\-\ not\\:\\ 0\\.011505715477454326\ \(0\)\
\-\ nodule\\:\\ 0\\.011502053520904188\ \(0\)\
\-\ many\\:\\ 0\\.011489500105517693\ \(0\)\
\-\ increasing\\:\\ 0\\.011477008076270757\ \(0\)\
\-\ family\\:\\ 0\\.011464576835727804\ \(0\)\
\-\ pathology\\:\\ 0\\.01143989437424186\ \(0\)\
\-\ infarction\\:\\ 0\\.01143989437424186\ \(0\)\
\-\ initially\\:\\ 0\\.01142764200116007\ \(0\)\
\-\ visualized\\:\\ 0\\.011379211832414998\ \(0\)\
\-\ placement\\:\\ 0\\.011379211832414998\ \(0\)\
\-\ thin\\:\\ 0\\.011343482370403994\ \(0\)\
\-\ reports\\:\\ 0\\.011331682742541026\ \(0\)\
\-\ shown\\:\\ 0\\.011296607387534111\ \(0\)\
\-\ additional\\:\\ 0\\.011296607387534111\ \(0\)\
\-\ typical\\:\\ 0\\.011262007108393358\ \(0\)\
\-\ sounds\\:\\ 0\\.011250577045072157\ \(0\)\
\-\ complications\\:\\ 0\\.011160932236954496\ \(0\)\
\-\ attenuation\\:\\ 0\\.011149944629088991\ \(0\)\
\-\ worsening\\:\\ 0\\.011128110180865134\ \(0\)\
\-\ colon\\:\\ 0\\.011095704483448108\ \(0\)\
\-\ related\\:\\ 0\\.011074326828232268\ \(0\)\
\-\ traumatic\\:\\ 0\\.011042592073666245\ \(0\)\
\-\ rate\\:\\ 0\\.011042592073666245\ \(0\)\
\-\ change\\:\\ 0\\.011042592073666245\ \(0\)\
\-\ midline\\:\\ 0\\.010959844276191929\ \(0\)\
\-\ about\\:\\ 0\\.010909455761122469\ \(0\)\
\-\ result\\:\\ 0\\.010909455761122469\ \(0\)\
\-\ 60\\:\\ 0\\.01089949623626387\ \(0\)\
\-\ pattern\\:\\ 0\\.010879692920888638\ \(0\)\
\-\ cough\\:\\ 0\\.010879692920888638\ \(0\)\
\-\ skin\\:\\ 0\\.010840540968493382\ \(0\)\
\-\ cardiac\\:\\ 0\\.01082118773282283\ \(0\)\
\-\ referred\\:\\ 0\\.010782915632873341\ \(0\)\
\-\ course\\:\\ 0\\.010763992473084304\ \(0\)\
\-\ lungs\\:\\ 0\\.010754583199498418\ \(0\)\
\-\ tumors\\:\\ 0\\.010717288889113512\ \(0\)\
\-\ metastasis\\:\\ 0\\.010680531206162679\ \(0\)\
\-\ appears\\:\\ 0\\.010671423835053189\ \(0\)\
\-\ clear\\:\\ 0\\.010564595103647557\ \(0\)\
\-\ since\\:\\ 0\\.010555891126264821\ \(0\)\
\-\ abnormalities\\:\\ 0\\.010555891126264821\ \(0\)\
\-\ involvement\\:\\ 0\\.010547216704040447\ \(0\)\
\-\ early\\:\\ 0\\.010504280989322786\ \(0\)\
\-\ reported\\:\\ 0\\.010495779767199535\ \(0\)\
\-\ vein\\:\\ 0\\.010445358099639493\ \(0\)\
\-\ including\\:\\ 0\\.010428769632970777\ \(0\)\
\-\ care\\:\\ 0\\.01041228818941252\ \(0\)\
\-\ they\\:\\ 0\\.01041228818941252\ \(0\)\
\-\ typically\\:\\ 0\\.01023002131979771\ \(0\)\
\-\ biopsy\\:\\ 0\\.010214769842315131\ \(0\)\
\-\ being\\:\\ 0\\.010154658483249845\ \(0\)\
\-\ heart\\:\\ 0\\.010132476449027523\ \(0\)\
\-\ side\\:\\ 0\\.010067063105559399\ \(0\)\
\-\ benign\\:\\ 0\\.010010291549415247\ \(0\)\
\-\ now\\:\\ 0\\.010003282999366316\ \(0\)\
\-\ 12\\:\\ 0\\.009961630746905694\ \(0\)\
\-\ neoplasm\\:\\ 0\\.009947896225163837\ \(0\)\
\-\ although\\:\\ 0\\.009920646741297584\ \(0\)\
\-\ inferior\\:\\ 0\\.00991387954557738\ \(0\)\
\-\ fever\\:\\ 0\\.00988030987867313\ \(0\)\
\-\ size\\:\\ 0\\.009867004562707497\ \(0\)\
\-\ inflammatory\\:\\ 0\\.009853768186512095\ \(0\)\
\-\ internal\\:\\ 0\\.009820974220245544\ \(0\)\
\-\ cases\\:\\ 0\\.009801498027633691\ \(0\)\
\-\ bilaterally\\:\\ 0\\.00971877599674139\ \(0\)\
\-\ study\\:\\ 0\\.00971877599674139\ \(0\)\
\-\ radiation\\:\\ 0\\.009656917892383767\ \(0\)\
\-\ out\\:\\ 0\\.009578678576885798\ \(0\)\
\-\ revealed\\:\\ 0\\.009555079195287988\ \(0\)\
\-\ medial\\:\\ 0\\.009485561575298257\ \(0\)\
\-\ superior\\:\\ 0\\.009474157025596099\ \(0\)\
\-\ adjacent\\:\\ 0\\.00944586642760386\ \(0\)\
\-\ any\\:\\ 0\\.00941788570000364\ \(0\)\
\-\ while\\:\\ 0\\.00941788570000364\ \(0\)\
\-\ 20\\:\\ 0\\.009401243198859948\ \(0\)\
\-\ will\\:\\ 0\\.009379220520312686\ \(0\)\
\-\ day\\:\\ 0\\.0092824024742121\ \(0\)\
\-\ show\\:\\ 0\\.009250928381336065\ \(0\)\
\-\ age\\:\\ 0\\.00914873015783191\ \(0\)\
\-\ diffuse\\:\\ 0\\.009138731652346164\ \(0\)\
\-\ only\\:\\ 0\\.009104041877334376\ \(0\)\
\-\ treated\\:\\ 0\\.009074678164496175\ \(0\)\
\-\ renal\\:\\ 0\\.009074678164496175\ \(0\)\
\-\ decreased\\:\\ 0\\.009026476453530767\ \(0\)\
\-\ negative\\:\\ 0\\.009021705929473076\ \(0\)\
\-\ neck\\:\\ 0\\.008914372987592933\ \(0\)\
\-\ abdomen\\:\\ 0\\.00889162470824128\ \(0\)\
\-\ evaluation\\:\\ 0\\.008887099259953282\ \(0\)\
\-\ loss\\:\\ 0\\.008878072342820351\ \(0\)\
\-\ wall\\:\\ 0\\.008864591494172444\ \(0\)\
\-\ appearance\\:\\ 0\\.008785167017488518\ \(0\)\
\-\ weeks\\:\\ 0\\.008733556880546483\ \(0\)\
\-\ likely\\:\\ 0\\.00870813761718344\ \(0\)\
\-\ edema\\:\\ 0\\.008691330879652117\ \(0\)\
\-\ all\\:\\ 0\\.00867463399086319\ \(0\)\
\-\ chronic\\:\\ 0\\.008649791510905551\ \(0\)\
\-\ old\\:\\ 0\\.00862571982848978\ \(0\)\
\-\ presented\\:\\ 0\\.008497829086171695\ \(0\)\
\-\ been\\:\\ 0\\.008490076076000778\ \(0\)\
\-\ months\\:\\ 0\\.008482346524292852\ \(0\)\
\-\ distal\\:\\ 0\\.008466957231424894\ \(0\)\
\-\ if\\:\\ 0\\.008466957231424894\ \(0\)\
\-\ axial\\:\\ 0\\.008417572803470592\ \(0\)\
\-\ fluid\\:\\ 0\\.008413813251812634\ \(0\)\
\-\ due\\:\\ 0\\.008376518941427729\ \(0\)\
\-\ prior\\:\\ 0\\.008153312964658595\ \(0\)\
\-\ both\\:\\ 0\\.00812631546223785\ \(0\)\
\-\ over\\:\\ 0\\.008102924449589136\ \(0\)\
\-\ increased\\:\\ 0\\.007880089563521415\ \(0\)\
\-\ follow\\:\\ 0\\.007855817505484253\ \(0\)\
\-\ into\\:\\ 0\\.007746465066670457\ \(0\)\
\-\ associated\\:\\ 0\\.007680775430019687\ \(0\)\
\-\ most\\:\\ 0\\.007583945732444704\ \(0\)\
\-\ demonstrate\\:\\ 0\\.007575814325397316\ \(0\)\
\-\ small\\:\\ 0\\.0075169619555105925\ \(0\)\
\-\ exam\\:\\ 0\\.00733578004816124\ \(0\)\
\-\ had\\:\\ 0\\.007260531794026067\ \(0\)\
\-\ lateral\\:\\ 0\\.007231988313941905\ \(0\)\
\-\ contrast\\:\\ 0\\.007080457302683788\ \(0\)\
\-\ female\\:\\ 0\\.007031880620723185\ \(0\)\
\-\ mass\\:\\ 0\\.005566287969739421\ \(0\)\
\-\ pain\\:\\ 0\\.005214559911371351\ \(0\)\
\-\ left\\:\\ 0\\.004970981488801197\ \(0\)\
